Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial-Reference-Cited by-同舟云学术

Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial

Published:2023-04 Issue: Volume:258 Page:60-68
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Branch Kelley R.H.,Probstfield Jeffrey L.,Bosch Jackie,Bhatt Deepak L.,Maggioni Aldo P.,Muehlhofer Eva,Avezum Alvaro,Widimsky Petr,Connolly Stuart J.,Yi Quilong,Shestakovska Olga,Yusuf Salim,Eikelboom John W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis;Bhatt;JAMA,2010

2. Risk factors for major adverse cardiovascular events after the first acute coronary syndrome;Okkonen;Ann Med,2021

3. Long-term risk of death and recurrent cardiovascular events following acute coronary syndromes;Gouda;PLOS ONE,2021

4. Risks of stroke recurrence and mortality after first and recurrent strokes in Denmark: a nationwide registry study;Skajaa;Neurology,2022

5. Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction;Rapsomaniki;Eur Heart J Qual Care Clin Outcomes,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe−/− mice;Atherosclerosis;2024-10

2. Impact of Bempedoic Acid on Total Cardiovascular Events;JAMA Cardiology;2024-03-01

3. Erkrankungen der Becken- und Beinarterien;Gefäßchirurgie;2024